US Stops Production Of AstraZeneca's COVID-19 Vaccines At A Baltimore-Based Vaccine Maker's Facility

Swarajya Staff

Apr 05, 2021, 11:06 AM | Updated 11:06 AM IST


In a major development, the United States (US)' Health and Human Services Department has stopped a Baltimore, Maryland-based vaccine manufacturer from producing doses of AstraZeneca's COVID-19 vaccines, reports Livemint.

The development comes days after Emergent BioSolutions had ruined a whopping 15 million doses of the COVID-19 vaccine developed by Johnson & Johnson (J&J) as it accidentally mixed up ingredients from two different vaccines. The mix-up forced the regulator to step in and delay the approval of the output from the facility.

Department has also asked J&J to install a new team to oversee all aspects of the manufacturing of the said facility. Meanwhile, Swedish-British pharmaceutical major AstraZeneca has said that it would work with President Joseph Biden's administration in the US to find an alternative site.

It should be noted that AstraZeneca's COVID-19 vaccine has been developed in collaboration with the University of Oxford. The same is being manufactured in India by Pune based Serum Institute of India (SII) under the name 'Covishield'.

Get Swarajya in your inbox.